Methods of preventing and removing trisulfide bonds
View Patent ↗The present invention pertains to methods of preventing and eliminating trisulfide bonds in proteins such as antibodies. In one embodiment, trisulfide bonds in proteins are converted to disulfide bonds as part of chromatographic purification procedures. In another embodiment, the formation of trisulfide bonds in proteins is inhibited by implementation of methods described herein during the cell culture production of such proteins. In another embodiment, monoclonal antibodies are produced by the methods described herein.
1. A method for reducing the formation of trisulfide bonds in antibodies or antigen-binding fragments thereof, wherein said method comprises cultivating mammalian cells producing said antibodies or antigen-binding fragments thereof in cell culture media under conditions selected from the group consisting of:
(a) maintaining or reducing the concentration of sulfur or sulfur-containing compounds in the cell culture media below a threshold level of 10 millimolar;
(b) harvesting the cell culture media when the cell culture is at approximately maximum cell density or at approximately peak production of the antibodies or antigen-binding fragments thereof; and
(c) a combination of (a) and (b), wherein the sulfur-containing compound is selected from:
(i) hydrogen sulfide;
(ii) sodium sulfide; and
(iii) sodium hydrogen sulfide.
2. The method of claim 1 , wherein said method comprises harvesting the cell culture media when the cell culture is at approximately maximum cell density.
3. The method of claim 1 , wherein said method comprises harvesting the cell culture media at approximately peak production of the antibodies or antigen-binding fragments thereof.
4. A method for reducing the formation of trisulfide bonds in antibodies or antigen-binding fragments thereof in a mammalian cell culture, wherein said method comprises maintaining the concentration of cysteine and/or cystine in the cell culture at or below a threshold level of 150 micromolar during cell cultivation.
5. The method of claim 4 , wherein said threshold level is about 50 micromolar.
6. The method of claim 1 , wherein the antibodies or antigen-binding fragments thereof are IgG1, IgG2, IgG3 or IgG4.
7. The method of claim 1 , wherein the antibodies or antigen-binding fragments thereof are IgG1.
8. The method of claim 1 , wherein the mammalian cells comprise CHO cells.
9. The method of claim 4 , wherein the method reduces heat induced fragmentation of the antibodies or antigen-binding fragments thereof compared to the antibodies or antigen-binding fragments thereof produced without maintaining the concentration of cysteine and/or cystine in the cell culture at or below the threshold level of 150 micromolar during cell cultivation, wherein the heat induced fragmentation is measured by denaturing, non-reducing capillary electrophoresis.
10. The method of claim 4 , wherein the antibodies or antigen-binding fragments thereof are IgG1, IgG2, IgG3 or IgG4.
11. The method of claim 10 , wherein the antibodies or antigen-binding fragments thereof are IgG1.
12. The method of claim 4 , wherein the cell culture comprises CHO cells.
13. The method of claim 2 , wherein the antibodies or antigen-binding fragments thereof are IgG1, IgG2, IgG3 or IgG4.
14. The method of claim 3 , wherein the antibodies or antigen-binding fragments thereof are IgG1, IgG2, IgG3 or IgG4.
15. The method of claim 13 , wherein the antibodies or antigen-binding fragments thereof are IgG1.
16. The method of claim 14 , wherein the antibodies or antigen-binding fragments thereof are IgG1.